Could a temporary lack of blood flow trigger Alzheimer's disease?

Health · Published 20 October 2026 Swipe more like this →

In short: For years, scientists have struggled to find the root cause of Alzheimer's disease. Recent research suggests we might be looking at the wrong starting point. Instead of just protein buildup, the culprit may be brain ischemia—a condition where insufficient blood flow triggers a cascade of genetic and cellular decay.

Brain ischemia occurs when blood flow to the brain fails to meet metabolic demands, depriving neurons of oxygen and glucose. This leads to a rapid depletion of adenosine triphosphate (ATP) within minutes. When ATP-dependent ion pumps fail, cells lose their electrochemical gradients, causing an influx of calcium that triggers glutamate release and proteolysis, eventually leading to neuronal injury. While permanent damage often occurs within minutes, researchers in 1974 demonstrated that mammalian brain ischemia lasting up to one hour could be at least partially recovered, opening a window for intervention.

A significant shift in neurological research is occurring as scientists link post-ischemic changes to the progression of Alzheimer's disease. Both conditions show predominant pathology in the hippocampus, including the development of amyloid plaques and neurofibrillary tangles. Research shows how ischemia triggers malfunctions within various Alzheimer's-linked genes, including RAGE, LRP1, apolipoproteins, α-synuclein, tau protein, mitophagy, autophagy, apoptosis, amyloid precursor protein, and secretases. Such evidence implies that ischemic injury might trigger the misfolding of proteins linked to disease, instead of being the initial cause.

The research highlights the importance of neuroimmune regulators like cortistatin. In studies using cortistatin-deficient mice, researchers found that a lack of this neuropeptide amplified ischemia-induced transcriptional programs, heightening neuroinflammation and worsening neurological outcomes. Conversely, administering cortistatin improved neuronal survival and preserved myelin and vascular integrity during both acute (48 hours) and subacute (7 days) phases. By understanding these genomic and proteomic conversions, scientists hope to develop causal therapies that target the underlying mechanisms of ischemia to prevent long-term dementia.

Clinically, ischemia can be focal—caused by thrombosis from atherosclerosis or embolisms from atrial fibrillation—or global, resulting from systemic hypoperfusion like cardiac arrest. Medical experts identify the 'ischemic penumbra' as a vital target; this hypoperfused region maintains some metabolic function and could be rescued via prompt treatment.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• When brain proteins turn blood vessels into fragile, leaking pipes
• The cellular breakdown of the brain is more than just aging
• A stroke is essentially a heart attack for the brain, requiring immediate medical intervention.
• Why a stroke is a race against time for your brain cells
• In Japan, half of all dementia comes from damaged blood vessels
• The active form of vitamin D does more than build bones
• Why your brain may struggle to accurately perceive the shape of your own body
• When the heart fails to pump, cardiogenic shock turns a heart attack deadly.
• Blurred vision is more than just a need for glasses; it is a vital signal.
• When your immune system forgets how to turn off
• When common microbes turn deadly: the hidden mechanics of bloodstream infections
• The invisible cargo of the frontier: how cattle drove disease across America

More in Morbidity · More in Health · Latest · A–Z · All topics